Measles has been in the spotlight in recent weeks. Between December 22, 2024, and March 20, 2025, reported measles cases in the US climbed from 1 to 378.1 This recent and rapid rise in cases has resulted in more than 3 times the number of cases than at this point last year. Also, during the first week of March 2025, there were 2 deaths of individuals who had positive test results for measles.2,3
Previously, the last reported death of an individual who had positive test results for measles was in 2015.4 The deaths on March 4 and 6, 2025, were of a school-aged child and an adult, both of whom were unvaccinated. In fact, 94% of cases reported as of March 7, 2025, were in unvaccinated individuals or those with unknown vaccination status.1
Amid these outbreaks, misinformation and confusion regarding measles and prevention measures have surfaced. Pharmacists are likely to encounter questions from patients, parents, and caregivers regarding the disease and vaccine recommendations. The following includes common questions and answers to help navigate these concerns and provide patient education.
About the Authors
Lauren B. Angelo, PharmD, MBA, is an associate professor and associate dean for academic affairs at Rosalind Franklin University of Medicine and Science College of Pharmacy in North Chicago, Illinois.
Laura E. Knockel, PharmD, BCACP, is a clinical associate professor at the University of Iowa College of Pharmacy in Iowa City.
Q: What might a person experience if infected with measles?
A: At first, a person with measles may appear to be experiencing cold or influenza symptoms. It often begins with a runny nose, cough, watery eyes, and fever.5 At day 2 or 3 of the infection, small white spots, which are called Koplik spots, appear inside the mouth, and a rash appears approximately 3 to 5 days after being infected. This rash looks like flat red spots and begins on the face around the hairline before spreading across the rest of the body. Sometimes, the spots have small bumps on them. Approximately 10% of people also have ear infections or diarrhea. Severe complications include pneumonia, swelling of the brain, and death. Hospitalization is common among those who are not vaccinated.5
Q: How contagious is measles?
A: Measles is very contagious. In fact, individuals without immunity to measles have a 90% chance of becoming infected if they are exposed to the virus.6 Exposure to the virus can occur by coming into contact with tiny droplets after someone who is infected coughs or sneezes. The virus can still be present in the air for up to 2 hours after an infected person leaves the room.7 A person with measles can infect others 4 days before to 4 days after the rash appears, which means people can transmit the virus before they realize they are infected.
Q: Who should be vaccinated against measles?
A: The CDC recommends that all children receive 2 doses of the measles vaccine: one at 12 through 15 months and a second dose at 4 through 6 years.6 If an adult was not vaccinated as a child, 1 dose is usually recommended. Adults at high risk for exposure and transmission, such as college students, health care providers, and international travelers, should receive 2 doses given 28 days apart. The measles vaccine should not be given to patients who are pregnant or have weakened immune systems.